Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica

Journal of Clinical Neuroscience

Volumn 20, Issue 2, 2013, Pages 278-280

  Liu, Caiyan ^a   Xu, Yan ^a   Cui, Liying ^a   Wang, Jianming ^a   Peng, Bin ^a   Zhong, Lizhen ^b   Chen, Xingwang ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Dalian Central Hospital   (China)

^c Shandong Traffic Hospital   (China)

Author keywords

Cerebrospinal fluid; Expanded Disability Status Scale score; Myelin basic protein; Neuromyelitis optica; Uric acid

Indexed keywords

IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; OLIGOCLONAL BAND; URIC ACID;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; URIC ACID; YOUNG ADULT;

EID: 84872357566     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.02.042     Document Type: Article

References (14)

1. D.M. Wingerchuk, V.A. Lennon, and S.J. Pittock Revised diagnostic criteria for neuromyelitis optica Neurology 66 2006 1485 1489
2. G.S. Scott, and D.C. Hooper The role of uric acid in protection against peroxynitrite-mediated pathology Med Hypotheses 56 2001 95 100
3. I. Dujmovic, T. Pekmezovic, and R. Obrenovic Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis Clin Chem Lab Med. 47 2009 848 853
4. G. Toncev, B. Milicic, and S. Toncev Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction Eur J Neurol 9 2002 221 226
5. M. Rentzos, C. Nikolaou, and M. Anagnostouli Serum uric acid and multiple sclerosis Clin Neurol Neurosurg 108 2006 527 531
6. C.M. Knapp, C.S. Constantinescu, and J.H.Y. Tan Serum uric acid levels in optic neuritis Mult Scler 10 2004 278 280
7. F. Peng, B. Zhang, and X. Zhong Serum uric acid levels of patients with multiple sclerosis and other neurological diseases Mult Scler 14 2008 188 196
8. S. Sotgiu, M. Pugliatti, and A. Sanna Serum uric acid and multiple sclerosis Neurol Sci 23 2002 183 188
9. A. Miller, L. Glass-Marmor, and M. Abraham Bio-markers of disease activity and response to therapy in multiple sclerosis Clin Neurol Neurosurg 106 2004 249 254
10. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
11. D.M. Wingerchuk, W.F. Hogancamp, and P.C. O'Brien The clinical course of neuromyelitis optica (Devic's syndrome) Neurology 53 1999 1107 1114
12. F. Peng, X. Zhong, and X. Deng Serum uric acid levels and neuromyelitis optica J Neurol 257 2010 1021 1026
13. J. Drulović, I. Dujmović, and N. Stojsavljević Uric acid levels in sera from patients with multiple sclerosis J Neurol 248 2001 121 126
14. C.S. Raine The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion Ann Neurol 36 1994 S61 S72